Recent clinical data showed that in type 2 diabetics, although visceral adiposity index (VAI) exhibit a significant positive correlation with visfatin serum levels, no significant differences was detected for adipsin, even when a two-step cluster analysis was performed in order to indentify altered adipocytokine profiles (8). The gene discussed is CFD; the disease is type 2 diabetes mellitus.